Human serum albumin (HSA), the most abundant protein in plasma, is a monomeric multi-
domain macromolecule, representing the main determinant of plasma oncotic pressure and …

Background: Ischemia-modified albumin has been proposed as a useful rule-out marker for
the diagnosis of acute coronary syndrome in the emergency department. Objective: To …

Objectives: The objective was to determine the value of ischemia‐modified albumin (IMA) in
the diagnosis of mesenteric embolism. The authors investigated whether or not plasma IMA …

Cisplatin (CP) is a chemotherapeutic agent used to treat various types of cancer;
nephrotoxicity is the most common adverse effect of the drug. We investigated the protective …

Objectives: This experimental study aimed to assess the changes in the levels of serum
ischemia‐modified albumin (IMA) and interleukin‐6 (IL‐6) by time in cases of acute …

The purpose of this study is to establish a novel pulmonary embolism (PE) risk prediction
model based on machine learning (ML) methods and to evaluate the predictive performance …

Objective The aim of this study was to evaluate the role of thiol/disulfide homeostasis in
acute pulmonary embolism (APE) and investigate its compliance to show hospital mortality …

Background Oxygen metabolism has an important role in the pathogenesis of rheumatoid
arthritis (RA). Abundant amounts of ROS have been identified in the synovial fluid of RA …

Objectives Ischemia-modified albumin (IMA), a new serum biomarker of myocardial
ischemia, has been introduced in the diagnosis of acute coronary syndrome. However, few …

The identification of circulating biomarkers of endothelial dysfunction (ED), a precursor to
atherosclerosis, in rheumatoid arthritis (RA) would facilitate early risk stratification and …